GEM-4C 558 -4%
GPT-61S 555 -3.8%
CL-SN55 553 -3.8%
CL-OP55 551 -4%
GPT-61TERR 547 -3.5%
GEM-4CM 546 -4%
CL-OP55EH 542 -3.9%
GPT-61SOLXH 541 -3.6%
GPT-61SOLH 527 -3.7%
CL-SN55XH 523 -3.5%
GEM-4CL 520 -3.9%
GPT-61TERRXH 507 -3.4%
CL-OP55H 506 -4%
GPT-61SOLM 500 -3.5%
KIMI-K31P 499 -3.5%
GEM-4AR 498 -3.9%
GPT-61TERRH 490 -3.2%
CL-OP55M 483 -3.6%
MUSE-WONDFUL 479 -3.8%
CL-SN55H 467 -3.3%
CL-HK55 463 -2.9%
GPT-61TERRM 462 -3.1%
GPT-6A 451 -4.7%
MUSE-WOND 451 -3.6%
CL-HK55XH 450 -3%
GPT-6ASTRXH 440 -4.8%
GROK-47 440 -3.1%
GROK-47H 438 -2.9%
GPT-6ASTRH 437 -4.8%
DSK-V-340615 436 -2.9%
QWEN-38X 428 -2.9%
GPT-61SOLL 423 -3.2%
GLM-53 420 -3%
MIMO-V26P 420 -2.6%
CL-HK55H 419 -2.8%
LING-31F1019 417 -2.6%
GEM-38F 416 -2.8%
GPT-6ASTRM 415 -4.6%
MMAX-M31F 414 -2.8%
GEM-38FM 412 -2.8%
GPT-61TERRNO 411 -2.8%
GROK-47L 410 -2.8%
DSK-V-3E48BD 410 -2.6%
GPT-6L 407 -2.6%
GLM-53F 407 -2.6%
STEP-5 405 -2.6%
CL-FABL51XH 403 -4.7%
GPT-61TERRL 403 -2.9%
MIMO-V26F 401 -2.4%
CL-FABL51 399 -4.5%
CL-SN55M 395 -2.9%
CL-OP55L 393 -3.4%
MIST-LARG4 390 -2.7%
CL-FABL51H 386 -4.5%
CL-HK55M 386 -2.3%
GPT-6LUNAXH 377 -2.6%
MUSE-SPAROPE 375 -2.6%
MIST-LARG4M 371 -2.4%
DSK-V4P 365 -2.4%
GPT-6LUNAH 365 -2.1%
GLM-53L 364 -2.4%
CL-SN55L 362 -2.7%
GEM-38FL 361 -2.4%
GPT-6ASTRL 359 -4.5%
CL-FABL51M 359 -4.5%
QWEN-827B 349 -2.2%
CL-HK55L 347 -2%
MMAX-M3 345 -2%
GPT-6LUNAM 344 -2.3%
DSK-V-02811D 344 -2%
K2-HORI375BA 342 -2%
REFL-BEAM 338 -2%
QWEN-827BM 332 -1.8%
CL-FABL51L 329 -4.4%
QWEN-827BL 320 -1.8%
NEMO-35SUPEV 313 -1.9%
INKL 295 -1.7%
NVID-NEMO3UL 295 -1.3%
GEM-35FLITE 295 -1.3%
GPT-6LUNAL 287 -1.4%
GPT-6LUNANON 286 -1%
NANB-333B 285 -2.7%
QWEN-827BNON 282 -1.4%
COMM-APLUS 266 -1.1%
MUSE-GLIM 263 -1.1%
NEMO-35LIGH 261 -0.8%
GRAN-428B 258 -0.8%
MIST-SMAL4 252 -0.4%
INKL-SM 235 -2.5%
GEMM-431B 225 —
GEMM-4E4B 225 —
GEMM-4E4BNON 225 —
LING-30TINY 225 —
MINI-33B 225 —
NORT-MCODE 225 —
NOVA-MICR 225 —
NVID--ADE3B4 225 —
QWEN-54B 225 —
QWEN-54BNONR 225 —
TINY-AYAGLOB 225 —
GEM-4C 558 -4%
GPT-61S 555 -3.8%
CL-SN55 553 -3.8%
CL-OP55 551 -4%
GPT-61TERR 547 -3.5%
GEM-4CM 546 -4%
CL-OP55EH 542 -3.9%
GPT-61SOLXH 541 -3.6%
GPT-61SOLH 527 -3.7%
CL-SN55XH 523 -3.5%
GEM-4CL 520 -3.9%
GPT-61TERRXH 507 -3.4%
CL-OP55H 506 -4%
GPT-61SOLM 500 -3.5%
KIMI-K31P 499 -3.5%
GEM-4AR 498 -3.9%
GPT-61TERRH 490 -3.2%
CL-OP55M 483 -3.6%
MUSE-WONDFUL 479 -3.8%
CL-SN55H 467 -3.3%
CL-HK55 463 -2.9%
GPT-61TERRM 462 -3.1%
GPT-6A 451 -4.7%
MUSE-WOND 451 -3.6%
CL-HK55XH 450 -3%
GPT-6ASTRXH 440 -4.8%
GROK-47 440 -3.1%
GROK-47H 438 -2.9%
GPT-6ASTRH 437 -4.8%
DSK-V-340615 436 -2.9%
QWEN-38X 428 -2.9%
GPT-61SOLL 423 -3.2%
GLM-53 420 -3%
MIMO-V26P 420 -2.6%
CL-HK55H 419 -2.8%
LING-31F1019 417 -2.6%
GEM-38F 416 -2.8%
GPT-6ASTRM 415 -4.6%
MMAX-M31F 414 -2.8%
GEM-38FM 412 -2.8%
GPT-61TERRNO 411 -2.8%
GROK-47L 410 -2.8%
DSK-V-3E48BD 410 -2.6%
GPT-6L 407 -2.6%
GLM-53F 407 -2.6%
STEP-5 405 -2.6%
CL-FABL51XH 403 -4.7%
GPT-61TERRL 403 -2.9%
MIMO-V26F 401 -2.4%
CL-FABL51 399 -4.5%
CL-SN55M 395 -2.9%
CL-OP55L 393 -3.4%
MIST-LARG4 390 -2.7%
CL-FABL51H 386 -4.5%
CL-HK55M 386 -2.3%
GPT-6LUNAXH 377 -2.6%
MUSE-SPAROPE 375 -2.6%
MIST-LARG4M 371 -2.4%
DSK-V4P 365 -2.4%
GPT-6LUNAH 365 -2.1%
GLM-53L 364 -2.4%
CL-SN55L 362 -2.7%
GEM-38FL 361 -2.4%
GPT-6ASTRL 359 -4.5%
CL-FABL51M 359 -4.5%
QWEN-827B 349 -2.2%
CL-HK55L 347 -2%
MMAX-M3 345 -2%
GPT-6LUNAM 344 -2.3%
DSK-V-02811D 344 -2%
K2-HORI375BA 342 -2%
REFL-BEAM 338 -2%
QWEN-827BM 332 -1.8%
CL-FABL51L 329 -4.4%
QWEN-827BL 320 -1.8%
NEMO-35SUPEV 313 -1.9%
INKL 295 -1.7%
NVID-NEMO3UL 295 -1.3%
GEM-35FLITE 295 -1.3%
GPT-6LUNAL 287 -1.4%
GPT-6LUNANON 286 -1%
NANB-333B 285 -2.7%
QWEN-827BNON 282 -1.4%
COMM-APLUS 266 -1.1%
MUSE-GLIM 263 -1.1%
NEMO-35LIGH 261 -0.8%
GRAN-428B 258 -0.8%
MIST-SMAL4 252 -0.4%
INKL-SM 235 -2.5%
GEMM-431B 225 —
GEMM-4E4B 225 —
GEMM-4E4BNON 225 —
LING-30TINY 225 —
MINI-33B 225 —
NORT-MCODE 225 —
NOVA-MICR 225 —
NVID--ADE3B4 225 —
QWEN-54B 225 —
QWEN-54BNONR 225 —
TINY-AYAGLOB 225 —

Delayed ticker data. Last calculated 5 Nov 2026, 11:04 pm Sydney time.

← Back to feed

AI Medical Chatbots Hit 95% in Lab Tests — Then Drop to 35% When Real Patients Talk to Them

Controlled evaluations of AI medical chatbots consistently report accuracy around 95% — which is why they’re being deployed at scale as a first-line health information layer. A BBC investigation published this week, drawing on converging research, puts a number on what happens when the same systems interact with actual patients: accuracy drops to approximately 35%.

The gap — 60 percentage points between lab performance and real-world performance — is not a model failure. It’s a measurement failure. Lab benchmarks present clean, complete, well-structured clinical descriptions. Real users give partial, distracted, meandering symptom reports where the relevant detail arrives in the wrong order, or doesn’t arrive at all.

The Mechanics of the Collapse

The problem is conversational — not computational. AI health systems are evaluated on cases constructed by medical professionals who know what information the model needs. Real patients don’t know what information the model needs. They describe their subjective experience, skip the objective details that would matter to a clinician, and use colloquial language that maps imprecisely to diagnostic categories.

In this environment, the stakes of phrasing asymmetry become acute. A wording difference of a few words — not a factual difference, just a phrasing difference — can produce advice recommendations that sit on opposite ends of the clinical action spectrum: “rest at home and monitor symptoms” versus “seek emergency care.”

A parallel evaluation published by Modern Healthcare, covering five major AI chatbot platforms, found 50% of AI medical advice was “problematic” — a broader category that includes incomplete, misleading, or inappropriately confident responses, not just factually wrong ones. A separate PublicTechnology analysis of the same five platforms found Grok performed worst.

The Deployment Problem

Roughly 25% of US adults used an AI tool for health information in the 30 days prior to an AP-NORC poll conducted in late 2025. That figure is increasing, and the use pattern matters: people are turning to AI chatbots for health questions at the point when they’re trying to decide whether to seek care — precisely the decision threshold where 35% accuracy and advice-flipping phrasing sensitivity are most consequential.

These systems were not designed for this use case in their current form. They were designed to answer health questions, and they’ve been deployed at scale because they answer most questions correctly in testing. The gap between “most questions correctly in testing” and “35% of real conversations” is not disclosed to users at the point of use.

What This Looks Like in Practice

A user describing chest tightness after exercise with shortness of breath might frame it as “I’ve been feeling a bit off after walking” — omitting the specifics that would trigger the right clinical response path. The same model that correctly identifies cardiac risk when given structured input generates a different risk assessment for the same underlying condition described informally.

The model hasn’t changed. The input distribution has.

The Accountability Gap

No current regulatory framework requires health AI systems to publish real-world accuracy figures alongside controlled benchmark performance. The FDA has guidance on AI medical devices, and the EU AI Act classifies high-risk AI applications including health — but accuracy disclosure norms for conversational health tools haven’t been formalised in either jurisdiction.

The practical effect: a chatbot can report 95% clinical accuracy in marketing materials and product documentation while operating at 35% accuracy with its actual user base. The 60-point gap is not visible to the users in that 25%-of-adults cohort making health decisions based on the answers they receive.

Key Numbers

  • Controlled test accuracy: ~95%
  • Real-user conversation accuracy: ~35%
  • Accuracy gap: ~60 percentage points
  • Problematic AI medical advice rate (Modern Healthcare): 50% across 5 platforms
  • US adults using AI for health info (AP-NORC, late 2025): ~25% in past 30 days
  • Worst performer (PublicTechnology evaluation): Grok
  • Clinical stakes of phrasing error: advice flip between home rest and emergency care